IMFINZI® (durvalumab) | Immunotherapy for Certain Cancers
IMFINZI® (durvalumab) is an immunotherapy approved to treat patients with unresectable hepatocellular carcinoma, bile duct cancer, gallbladder cancer, NSCLC, ES-SCLC, and …
Durvalumab - Wikipedia
Durvalumab, [8] sold under the brand name Imfinzi, is an anti-cancer medication used for treatment of various types of cancer. [6] It was developed by Medimmune/AstraZeneca. [9] It …
Imfinzi: Uses, Dosage, Side Effects & More - Drugs.com
Dec 9, 2024 · Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile duct and gallbladder cancer, hepatocellular carcinoma, and endometrial …
IMFINZI® (durvalumab) Immunotherapy for Cancer | HCP Site
Discover IMFINZI® (durvalumab), an immunotherapy for adults with metastatic NSCLC, unresectable Stage III NSCLC, extensive-stage SCLC, advanced BTC, unresectable HCC, …
Imfinzi (durvalumab) - Uses, Side Effects, and More - WebMD
Sep 17, 2024 · Imfinzi (durvalumab) is commonly used to treat the following types of cancer. Certain types of lung cancer including non-small cell lung cancer (NSCLC) and small cell lung …
FDA approves neoadjuvant/adjuvant durvalumab for resectable …
On August 15, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with platinum-containing chemotherapy as neoadjuvant treatment, followed by …
What is IMFINZI® (durvalumab) – Treatment for Unresectable …
IMFINZI® (durvalumab) is an FDA-approved immunotherapy for people with unresectable Stage 3 non-small cell lung cancer (NSCLC) who were previously treated with concurrent …
IMFINZI- durvalumab injection, solution - DailyMed
IMFINZI (durvalumab) Injection for intravenous use is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow solution, free from visible particles. Each 500 mg vial of …
Imfinzi - European Medicines Agency (EMA)
The active substance in Imfinzi, durvalumab, is a monoclonal antibody, a type of protein designed to attach to a protein called PD-L1, which is present on the surface of many cancer cells. PD …
Imfinzi (durvalumab): Side effects, dosage, uses, and more
Feb 7, 2024 · Imfinzi (durvalumab) is a prescription drug used to treat certain cancers in adults, such as lung cancer. Learn about side effects, uses, and more.